Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CYLD Protein (AA 1-226) (His-IF2DI Tag)

CYLD Origine: Humain Hôte: Escherichia coli (E. coli) Recombinant Greater than 95 % by SDS-PAGE gel analyses WB, ELISA
N° du produit ABIN7122546
  • Antigène Voir toutes CYLD Protéines
    CYLD (Cylindromatosis (Turban Tumor Syndrome) (CYLD))
    Type de proteíne
    Recombinant
    Attributs du protein
    AA 1-226
    Origine
    • 6
    • 1
    Humain
    Source
    • 3
    • 2
    • 1
    • 1
    Escherichia coli (E. coli)
    Purification/Conjugué
    Cette CYLD protéine est marqué à la His-IF2DI Tag.
    Application
    Western Blotting (WB), ELISA
    Pureté
    Greater than 95 % by SDS-PAGE gel analyses
    Stérilité
    0.2 μm filtered
  • Indications d'application
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Centrifuge the vial at 10,000 rpm for 1 minute, reconstitute at 200 μg/mL in sterile distilled water by gentle pipetting 2-3 times, don't vortex
    Buffer
    Lyophilized from a 0.2 μm filtered solution in PBS with 5 % trehalose, pH 7.4
    Stock
    4 °C,-20 °C
    Stockage commentaire
    -20°C for 12 months as lyophilized, 2-8°C for 1 month under sterile conditions after reconstitution
    Date de péremption
    12 months
  • Antigène
    CYLD (Cylindromatosis (Turban Tumor Syndrome) (CYLD))
    Autre désignation
    CYLD (CYLD Produits)
    Synonymes
    BRSS Protein, CDMT Protein, CYLD1 Protein, CYLDI Protein, EAC Protein, MFT Protein, MFT1 Protein, SBS Protein, TEM Protein, USPL2 Protein, 2010013M14Rik Protein, 2900009M21Rik Protein, C130039D01Rik Protein, mKIAA0849 Protein, cyld Protein, LRRGT00003 Protein, Rp1 Protein, Rp1h Protein, CYLD lysine 63 deubiquitinase Protein, cylindromatosis (turban tumor syndrome), a Protein, CYLD Protein, Cyld Protein, cylda Protein
    Sujet
    BRSS, CDMT, CYLD, CYLD1, CYLD1MFT, CYLDI, cylindromatosis (turban tumor syndrome), Deubiquitinating enzyme CYLD, EAC, EC 3.1.2.15, EC 3.4.19.12, FLJ20180, FLJ31664, KIAA0849FLJ78684, MFT1, probable ubiquitin carboxyl-terminal hydrolase CYLD
    Poids moléculaire
    46 kDa
    UniProt
    Q9NQC7
    Pathways
    Apoptose, Activation of Innate immune Response
Vous êtes ici: